A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)
Clinical trial NCT07266558 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07266558
- Sponsor
- ModernaTX, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-26
- Primary completion
- 2027-06-16
- Enrollment
- 30000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.